Royce & Associates’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.12M Buy
1,808,448
+102,299
+6% +$347K 0.05% 461
2025
Q4
$5.54M Sell
1,706,149
-55,615
-3% -$187K 0.06% 446
2025
Q3
$5.06M Buy
1,761,764
+484,908
+38% +$1.24M 0.05% 467
2025
Q2
$3.08M Sell
1,276,856
-51,588
-4% -$108K 0.03% 544
2025
Q1
$2.94M Buy
1,328,444
+369,559
+39% +$1.46M 0.03% 529
2024
Q4
$5.23M Buy
958,885
+50,107
+6% +$322K 0.05% 467
2024
Q3
$7.55M Buy
908,778
+514,332
+130% +$4.45M 0.07% 388
2024
Q2
$2.82M Buy
394,446
+378,009
+2,300% +$3.26M 0.03% 579
2024
Q1
$143K Buy
+16,437
New +$111K ﹤0.01% 844
2023
Q1
Sell
-54,106
Closed -$774K 936
2022
Q4
$774K Buy
+54,106
New +$852K 0.01% 784
2022
Q3
Sell
-458,788
Closed -$13M 956
2022
Q2
$13M Buy
458,788
+109,303
+31% +$3.46M 0.13% 224
2022
Q1
$12.3M Buy
+349,485
New +$11.7M 0.1% 293

Other funds holding MRVI